Non-malignant late effects in lymphoma patients treated with autologous hematopoietic stem cell transplantation

Creative Commons License

Sirmatel P., Yilmaz H., GÜNDÜZ E.

EUROPEAN JOURNAL OF THERAPEUTICS, vol.23, no.3, pp.106-110, 2017 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 23 Issue: 3
  • Publication Date: 2017
  • Doi Number: 10.5152/eurjther.2017.66
  • Journal Name: EUROPEAN JOURNAL OF THERAPEUTICS
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.106-110
  • Keywords: Lymphoma, autologous hematopoietic stem cell transplantation, non-malignant, late effect, BONE-MARROW-TRANSPLANTATION, HIGH-DOSE CHEMOTHERAPY, COMPLICATIONS, CHILDHOOD, SURVIVORS, HODGKIN, ADULTS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objective: Developments in transplantation procedures have led to an increase in the number of long-term survivors after hematopoietic stem cell transplantation (HSCT). In this study, we investigated non-malignant late side effects after autologous HSCT (AHSCT) in lymphoma patients.